GAP43 Antibody [P10H20] | Primary Antibodies

Application: Reactivity: Human, Mouse, Rat

Lane 1: Mouse brain

Usage Information

Dilution
WB1:1000 IP1:50 IF1:200-1:400

Application
WB, IP, IF

Reactivity
Human, Mouse, Rat

Source
Rabbit Monoclonal Antibody

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage (from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

Predicted MW
38 kDa, 43 kDa

Datasheet & SDS

Biological Description

Specificity
GAP43 Antibody [P10H20] detects endogenous levels of total GAP43 protein.

Clone
P10H20

Synonym(s)
Neuromodulin; Axonal membrane protein GAP-43; Growth-associated protein 43; Neural phosphoprotein B-50; pp46; GAP43

Background
GAP43 (growth associated protein 43) is a neuron specific, intrinsically disordered protein that concentrates in axonal growth cones and synaptic terminals and functions as a central modulator of neurite outgrowth, axon pathfinding, and synaptic plasticity during development and regeneration. It is targeted to the cytoplasmic face of the inner leaflet of the plasma membrane through dual palmitoylation and associates with phosphatidylinositol 4,5 bisphosphate and calmodulin, enabling it to translate presynaptic and growth cone calcium signals into cytoskeletal remodeling and membrane trafficking. A key regulatory site, Ser41, is phosphorylated by protein kinase C in a Ca2+ dependent manner, and this phosphorylation dynamically controls the affinity of GAP43 for calmodulin, thereby coordinating the release of actin associated regulatory complexes, actin polymerization at the leading edge, and microtubule advance into the growth cone, which collectively drive axon elongation and branching. In the developing and adult brain, GAP43 rich circuits are essential for formation of functional cortical connectivity, hippocampal plasticity, and activity dependent refinement of synaptic terminals, making GAP43 expression and phosphorylation status widely used readouts for regenerative competence and synaptic remodeling in experimental models. In schizophrenia and Alzheimer’s disease, altered GAP43 expression and mislocalization are observed in specific brain regions, where aberrant regulation of growth cone like dynamics and synaptic stability may contribute to disrupted connectivity and cognitive decline, so that GAP43 dependent signaling is ultimately dysregulated in neurodevelopmental and neurodegenerative contexts.

Background

GAP43 (growth associated protein 43) is a neuron specific, intrinsically disordered protein that concentrates in axonal growth cones and synaptic terminals and functions as a central modulator of neurite outgrowth, axon pathfinding, and synaptic plasticity during development and regeneration. It is targeted to the cytoplasmic face of the inner leaflet of the plasma membrane through dual palmitoylation and associates with phosphatidylinositol 4,5 bisphosphate and calmodulin, enabling it to translate presynaptic and growth cone calcium signals into cytoskeletal remodeling and membrane trafficking. A key regulatory site, Ser41, is phosphorylated by protein kinase C in a Ca2+ dependent manner, and this phosphorylation dynamically controls the affinity of GAP43 for calmodulin, thereby coordinating the release of actin associated regulatory complexes, actin polymerization at the leading edge, and microtubule advance into the growth cone, which collectively drive axon elongation and branching. In the developing and adult brain, GAP43 rich circuits are essential for formation of functional cortical connectivity, hippocampal plasticity, and activity dependent refinement of synaptic terminals, making GAP43 expression and phosphorylation status widely used readouts for regenerative competence and synaptic remodeling in experimental models. In schizophrenia and Alzheimer’s disease, altered GAP43 expression and mislocalization are observed in specific brain regions, where aberrant regulation of growth cone like dynamics and synaptic stability may contribute to disrupted connectivity and cognitive decline, so that GAP43 dependent signaling is ultimately dysregulated in neurodevelopmental and neurodegenerative contexts.

References
https://pubmed.ncbi.nlm.nih.gov/9023877/ https://pubmed.ncbi.nlm.nih.gov/3059197/

Reference Table for Selecting PVDF Membrane Pore Size Specifications

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%